No evidence for essential differences between the effects of insulin glargine, insulin detemir and NPH [neutral protamine Hagedorn] insulin on glucose metabolism after a single injection as assessed by 24-h euglycemic clamp studies in healthy humans
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine; Insulin suspension isophane
- Indications Diabetes mellitus
- Focus Pharmacodynamics
- 07 Nov 2012 Planned number of patients changed from 10 to 12 as reported by European Clinical Trials Database.
- 01 Jul 2010 Actual volunteer numbers reported as 10
- 11 Dec 2007 New trial record.